Detalhe da pesquisa
1.
Analyses of the FranceCoag cohort support differences in immunogenicity among one plasma-derived and two recombinant factor VIII brands in boys with severe hemophilia A.
Haematologica;
103(1): 179-189, 2018 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29025913
2.
A national French noninterventional study to assess the long-term safety and efficacy of reformulated nonacog alfa.
Transfusion;
57(4): 1066-1071, 2017 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28337764
3.
Long-term results of ankle arthrodesis in children and adolescents with haemophilia.
Int Orthop;
41(8): 1579-1584, 2017 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28424853
4.
Recombinant factor VIII products and inhibitor development in previously untreated boys with severe hemophilia A.
Blood;
124(23): 3398-408, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25253771
5.
Notes from the Field: Fatal Infection Associated with Equine Exposure - King County, Washington, 2016.
MMWR Morb Mortal Wkly Rep;
65(30): 788, 2016 Aug 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27490189
6.
EQOFIX: a combined economic and quality-of-life study of hemophilia B treatments in France.
Transfusion;
55(7): 1787-97, 2015 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25652955
7.
Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A.
Haematologica;
104(8): e369-e372, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30705098
8.
Development of inhibitory antibodies to therapeutic factor VIII in severe hemophilia A is associated with microsatellite polymorphisms in the HMOX1 promoter.
Haematologica;
98(10): 1650-5, 2013 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23716558
9.
Response: Confounding by indication is unlikely to explain the higher inhibitor incidence in boys treated with a recombinant FVIII product.
Blood;
125(24): 3817-9, 2015 Jun 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26069335
10.
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
Blood;
114(9): 1900-3, 2009 Aug 27.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19549989
11.
Bleeding risk assessment in hemophilia A carriers from Dakar, Senegal.
Blood Coagul Fibrinolysis;
28(8): 642-645, 2017 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28731872
12.
LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B.
JCI Insight;
1(16): e88643, 2016 Oct 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27734030
13.
Full-length sucrose-formulated recombinant factor VIII for treatment of previously untreated or minimally treated young children with severe haemophilia A: results of an international clinical investigation.
Thromb Haemost;
93(3): 457-67, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15735795
14.
Apoptotic Platelet Events Are Not Observed in Severe von Willebrand Disease-Type 2B Mutation p.V1316M.
PLoS One;
10(12): e0143896, 2015.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26645283
15.
Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level.
AIDS;
18(1): 45-9, 2004 Jan 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15090828
16.
Extracorporeal adsorption of anti-factor VIII allo-antibodies on randomly functionalized polystyrene resins.
Thromb Haemost;
91(2): 259-66, 2004 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-14961152
17.
Effects of trimethoprim-sulfadiazine on thyroid function of horses.
J Vet Intern Med;
18(3): 370-3, 2004.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15188829
18.
Peritoneal fluid from a febrile foal.
Vet Clin Pathol;
31(4): 189-91, 2002.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12447781
19.
Characteristics, mechanisms of action, and epitope mapping of anti-factor VIII antibodies.
Clin Rev Allergy Immunol;
37(2): 67-79, 2009 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19172415
20.
Successful conservative treatment of traumatic subacute subdural haematomas in neonates with haemophilia A.
Childs Nerv Syst;
24(6): 679-83, 2008 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18034248